Harpoon therapeutics, inc. (HARP)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16
Revenue
Total revenue

5,777

4,750

708

-

Operating expenses
Research and development

41,592

26,368

13,622

7,778

General and administrative

22,391

6,106

3,614

3,369

Total operating expenses

63,983

32,474

17,236

11,147

Loss from operations

-58,206

-27,724

-16,528

-11,147

Interest income

2,676

395

78

6

Interest expense

-

-

285

261

Other expense

42

37

95

4

Net loss

-55,572

-27,366

-16,830

-

Other comprehensive loss:
Net unrealized gain on marketable securities

41

-

-

-

Comprehensive loss

-55,531

-27,366

-16,830

-

Net loss and comprehensive loss

-

-

-

-11,406

Net loss per share, basic and diluted

-2.56

-25.65

-18.81

-21.61

Weighted-average common shares used in computing net loss per share, basic and diluted

21,746

1,066

894

527

Collaboration and License
Total revenue

5,777

4,750

708

-